Assesment of Multiomics Profiles in Health and Disease.
Launched by THE INSTITUTE OF MOLECULAR AND TRANSLATIONAL MEDICINE, CZECH REPUBLIC · Jun 8, 2020
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Assessment of Multiomics Profiles in Health and Disease," is studying how different biological profiles relate to health and disease in the Czech population. Specifically, it aims to understand genetic information, protein levels, and other biological markers to see how they may be linked to various diseases. The researchers hope to gather important information that can help in identifying genetic risks for diseases in the future.
If you are between the ages of 18 and 68 and generally healthy (meaning you don’t have any family history of certain genetic diseases or current serious health conditions), you may be eligible to participate. The study is currently recruiting participants, and those chosen will provide biological samples for analysis. It’s important to note that participants should not be taking long-term medications or have any significant health issues at the time of sampling. Being part of this study could contribute to valuable research that enhances our understanding of health and disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age 18 - 68 years
- * (for the first 1100 subjects):
- • healthy volunteers without genetically dependent disease and without such a disease in a family
- • healthy volunteer without the preliminary evidence of civilizational diseases such as hypertension, diabetes, autoimmune and tumor diseases or acute infectional diseases; clinically manifesting cardiovascular or pulmonary disability.
- • subject without permanent of long-term medication in the time of biological sampling.
- Exclusion Criteria:
- • not complying with inclusion criteria
About The Institute Of Molecular And Translational Medicine, Czech Republic
The Institute of Molecular and Translational Medicine (IMTM) in the Czech Republic is a leading research institution dedicated to advancing the fields of molecular biology and translational medicine. With a focus on bridging the gap between laboratory research and clinical applications, IMTM aims to develop innovative therapeutic strategies and improve patient outcomes. The institute fosters a collaborative environment that brings together experts in various disciplines, including genetics, pharmacology, and clinical research, to drive scientific discovery and facilitate the translation of findings into practical medical solutions. Through rigorous clinical trials and a commitment to ethical research practices, IMTM is at the forefront of enhancing healthcare and addressing unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Olomouc, , Czechia
Patients applied
Trial Officials
Marian Hajduch, MD, PhD.
Study Director
IMTM, Palacky University in Olomouc, Faculty of Medicine and Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials